Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow
FranceStudy of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy
FranceStudy of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy
FranceStudy Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma
FranceStudy of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors
FranceStudy on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients
FranceStudy of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy
FranceStudy on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment
FranceStudy on Dalbavancin and Rifampicin for Treating Prosthetic Joint Infections in Patients with Hip, Knee, and Shoulder Replacements
FranceStudy of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy
FranceStudy on Azithromycin for Treating Chronic Sinusitis in Adults
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
